Description
| Product Name | CAT.No | Size |
| Chlamydia Test | RPCH0020 | 20T |
| Chlamydia Test | RPCH0040 | 40T |
Product Description
The Biorex Diagnostics Chlamydia Test is a rapid immunochromatographic assay designed for the qualitative detection of Chlamydia trachomatis antigens in human endocervical, urethral, urine, or ocular specimens. This easy-to-use test provides fast, reliable results to support early diagnosis, treatment, and public health monitoring of Chlamydia infections. By delivering accurate and timely screening, the assay allows healthcare providers to initiate prompt interventions, reduce the risk of complications, and limit the spread of infection in both clinical and community settings. Its versatility and rapid workflow make it suitable for clinics, hospitals, laboratories, and field-based testing programmes.
Key Features
- Rapid Detection – qualitative results available within minutes, enabling quick clinical decision-making.
- High Sensitivity and Specificity – ensures accurate identification of Chlamydia trachomatis infections with minimal false positives or negatives.
- Versatile Sample Types – compatible with endocervical, urethral, urine, and ocular specimens for flexible use in different testing environments.
- Instrument-Free Operation – ideal for point-of-care testing, field diagnostics, or laboratory-based screening.
- Ready-to-Use Format – minimal preparation required, with simple visual interpretation and reduced handling errors.
Benefits
Routine use of the Chlamydia Test enables early recognition of infections, supporting timely clinical intervention and patient management. The test’s high analytical performance helps healthcare professionals accurately identify infections, monitor treatment effectiveness, and reduce disease transmission. Its rapid workflow and non-reliance on specialized instruments make it particularly suitable for community health initiatives, mobile clinics, and resource-limited environments. The test supports sexual health programmes, prenatal screening, and public health monitoring efforts by providing consistent, reliable results that inform clinical and epidemiological decisions.
By integrating the Biorex Chlamydia Test into routine screening practices, laboratories and healthcare providers can improve patient outcomes, enhance infection control strategies, and contribute to effective STI surveillance. Its combination of speed, reliability, and versatility makes it an indispensable tool for comprehensive Chlamydia detection and public health support.
Contact Us for more information.